Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

G. Chitadze, A. Stengel, C. John-Klaua, J. Bruckmüller, H. Trautmann, M. Kotrova, F. Darzentas, M. Kelm, K. Pal, N. Darzentas, L. Bastian, B. Kehden, W. Wessels, AS. Ströh, HH. Oberg, PM. Altrock, C. Baer, M. Meggendorfer, N. Gökbuget, CD....

. 2023 ; 141 (13) : 1640-1644. [pub] 2023Mar30

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010631

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010631
003      
CZ-PrNML
005      
20230801132541.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1182/blood.2022017249 $2 doi
035    __
$a (PubMed)36450137
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chitadze, Guranda $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany $u Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany $1 https://orcid.org/0000000196094643
245    10
$a Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia / $c G. Chitadze, A. Stengel, C. John-Klaua, J. Bruckmüller, H. Trautmann, M. Kotrova, F. Darzentas, M. Kelm, K. Pal, N. Darzentas, L. Bastian, B. Kehden, W. Wessels, AS. Ströh, HH. Oberg, PM. Altrock, C. Baer, M. Meggendorfer, N. Gökbuget, CD. Baldus, C. Haferlach, M. Brüggemann
650    _2
$a lidé $7 D006801
650    12
$a akutní lymfatická leukemie $x genetika $7 D054198
650    _2
$a nádorový supresorový protein p53 $x genetika $7 D016159
650    _2
$a mutace $7 D009154
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stengel, Anna $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a John-Klaua, Cathrin $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany
700    1_
$a Bruckmüller, Julien $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u Solana Research GmbH, Windeby, Germany $1 https://orcid.org/0000000239009833
700    1_
$a Trautmann, Heiko $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Kotrova, Michaela $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Darzentas, Franziska $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Kelm, Miriam $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Pal, Karol $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000277264691
700    1_
$a Darzentas, Nikos $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Bastian, Lorenz $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany $u Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany
700    1_
$a Kehden, Britta $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Wessels, Wiebke $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Ströh, Aeint-Steffen $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany
700    1_
$a Oberg, Hans-Heinrich $u Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany
700    1_
$a Altrock, Philipp M $u Department of Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Ploen, Germany
700    1_
$a Baer, Constance $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a Meggendorfer, Manja $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a Gökbuget, Nicola $u Department of Medicine II, Goethe University Hospital, Frankfurt, Germany
700    1_
$a Baldus, Claudia D $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany $u Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany
700    1_
$a Haferlach, Claudia $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a Brüggemann, Monika $u Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany $u University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany $u Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany $1 https://orcid.org/0000000155145010
773    0_
$w MED00000807 $t Blood $x 1528-0020 $g Roč. 141, č. 13 (2023), s. 1640-1644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36450137 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132537 $b ABA008
999    __
$a ok $b bmc $g 1963211 $s 1196896
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 141 $c 13 $d 1640-1644 $e 2023Mar30 $i 1528-0020 $m Blood $n Blood $x MED00000807
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace